←

ALGN · Align Technology, Inc.

Healthcare NMS United States aligntech.com ↗
Val — — Gro — — Qua — — Mom — — Sta — — Cap— P/S2.64 P/E— Fwd P/E12.40 PEG0.64 52W— – — RSI— Target$188.86 (+22.9%) Beta1.67 Div—
Loading chart…
RSI ()
◈ Pattern Overlays
Loading patterns…
Medical Instruments & Supplies Tempe, United States 20,435 employees
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low — 52W High
Position in Range —
RSI (14)
0 · Oversold RSI 57 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
4Bullish
7Bearish
0Neutral

Key Signals 1

▼ Double Top Major reversal 2026-08-19 · $164.75
Two peaks ~$189.47 — bearish reversal confirmed
Learn more →

Momentum Signals 10

▲ MACD Bullish Crossover 2026-06-25 · $175.71
▲ MACD Bullish Crossover 2026-08-10 · $176.04
▲ MACD Bullish Crossover 2026-09-22 · $153.29
▲ MACD Bullish Crossover 2026-10-08 · $141.03

View overlays on the price chart via Overview tab → Pattern Overlays.

EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
75% 6/8 quarters
Wall Street Consensus
BUY
8
7
1
BuyHoldSell
Price Target Range
$188.86 +22.9% upside
Low $155 — High $215
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 70.74%Last 12 Months
Operating Margin 18.25%Last 12 Months
Return on Equity 10.15%Last 12 Months
Revenue Growth 4.30%Year over Year
Free Cash Flow 594.11MLast 12 Months
Free Cash Flow Yield —Last 12 Months
Balance Sheet
Debt / Equity 2.85Most Recent Quarter
Current Ratio 1.40Most Recent Quarter
Cash 1.10BMost Recent Quarter
Total Debt 120.84MMost Recent Quarter
Net Debt —Most Recent Quarter
How ALGN Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap10.91B
Enterprise Value9.93B
Trailing P/E26.44
Forward P/E12.40
PEG Ratio (5yr)0.64
Price/Sales (ttm)2.64
Price/Book (mrq)2.59
EV/Revenue2.40
EV/EBITDA10.73
Share Statistics
Avg Vol (3m)934.32K
Shares Outstanding71.04M
Float66.84M
% Held by Insiders6.13%
% Held by Institutions104.23%
Short Ratio4.23
Short % of Float6.67%
Profitability
Gross Margin70.74%
Operating Margin (ttm)18.25%
Profit Margin9.99%
Return on Assets (ttm)7.56%
Return on Equity (ttm)10.15%
Income Statement
Revenue (ttm)4.14B
Revenue Growth (yoy)4.30%
Gross Profit (ttm)2.93B
EBITDA925.66M
Net Income (ttm)413.58M
Diluted EPS (ttm)5.81
EPS Growth (yoy)-12.10%
Balance Sheet
Total Cash (mrq)1.10B
Total Debt (mrq)120.84M
Debt / Equity (mrq)2.85
Current Ratio (mrq)1.40
Book Value / Share59.41
Operating CF (ttm)755.70M
Free Cash Flow (ttm)594.11M
Trading & Dividends
Beta (5Y)1.67
50-Day MA150.82
200-Day MA168.99
Fwd Dividend Yield0.00%
Payout Ratio0.00%

No dividend history available for ALGN.

Ownership Breakdown
Institutional 104.23% Insider 6.13%
Short Interest 6.67% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in ALGN in their latest SEC 13F filing.

Loading…
Insider Transactions
Open-market buys & sells · one dot per day, sized by $ · follows the filters below
Date Insider Role Transaction Shares Price Value